Hardin Capital Partners’s Medtronic MDT Stock Holding History

Hardin Capital Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,391	Closed	-$230K	–	142
2025 Q4	$230K	Buy	+2,391	New	+$232K	0.11%	116
2025 Q2	–	Sell	-2,675	Closed	-$240K	–	118
2025 Q1	$240K	Sell	2,675 -297	-10%	-$26.6K	0.15%	104
2024 Q4	$237K	Buy	2,972 +93	+3%	+$8.05K	0.14%	103
2024 Q3	$254K	Sell	2,879 -50	-2%	-$4.21K	0.14%	99
2024 Q2	$231K	Buy	+2,929	New	+$240K	0.15%	100

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hardin Capital Partners's MDT Position: Q1 2026 in Review

Hardin Capital Partners sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,391 shares — an estimated $230K sold.

Hardin Capital Partners first reported a position in MDT in Q2 2024 and held it in 5 quarters. The position peaked at $254K in Q3 2024. 2,233 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Hardin Capital Partners reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
Hardin Capital Partners sold 2,391 Medtronic shares in Q1 2026, an estimated $230K.
Hardin Capital Partners first reported a position in Medtronic in Q2 2024 and held it in 5 quarters.
Hardin Capital Partners's Medtronic position peaked at $254K in Q3 2024.
2,233 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Hardin Capital Partners's 13F filing for Q1 2026, filed 8 Apr 2026.